doxazosin has been researched along with Iris Diseases in 14 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
Iris Diseases: Diseases, dysfunctions, or disorders of or located in the iris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The association between intraoperative floppy iris syndrome (IFIS) and tamsulosin has been well-described." | 7.79 | Intraoperative floppy iris syndrome (IFIS) in patients receiving tamsulosin or doxazosin-a UK-based comparison of incidence and complication rates. ( Al-Ahmar, B; Haridas, A; Hingorani, M; Syrimi, M, 2013) |
| "To evaluate risk factors (hypertension, diabetes mellitus, and current tamsulosin, alfuzosin, terazosin, or doxazosin use) for intraoperative floppy iris syndrome (IFIS) in patients undergoing phacoemulsification cataract surgery." | 4.87 | Risk factors for intraoperative floppy iris syndrome: a meta-analysis. ( Chatziralli, IP; Sergentanis, TN, 2011) |
| "The association between intraoperative floppy iris syndrome (IFIS) and tamsulosin has been well-described." | 3.79 | Intraoperative floppy iris syndrome (IFIS) in patients receiving tamsulosin or doxazosin-a UK-based comparison of incidence and complication rates. ( Al-Ahmar, B; Haridas, A; Hingorani, M; Syrimi, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (71.43) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haridas, A | 1 |
| Syrimi, M | 1 |
| Al-Ahmar, B | 1 |
| Hingorani, M | 1 |
| Grzybowski, A | 1 |
| Krzyżanowska-Berkowska, P | 1 |
| Arikan, G | 1 |
| Demir, O | 1 |
| Yaman, A | 1 |
| Bozkurt, O | 1 |
| Saatci, AO | 1 |
| Durak, I | 1 |
| Esen, A | 1 |
| Mamalis, N | 1 |
| Chatziralli, IP | 1 |
| Sergentanis, TN | 1 |
| Casuccio, A | 1 |
| Cillino, G | 1 |
| Pavone, C | 1 |
| Spitale, E | 1 |
| Cillino, S | 1 |
| Schwinn, DA | 1 |
| Afshari, NA | 1 |
| El-Ghatit, AM | 1 |
| Muqit, MM | 1 |
| Menage, MJ | 1 |
| Dhingra, N | 1 |
| Rajkumar, KN | 1 |
| Kumar, V | 1 |
| Au, L | 1 |
| Wechsler, D | 1 |
| Fenerty, C | 1 |
| Herd, MK | 1 |
| Cheung, CM | 1 |
| Awan, MA | 1 |
| Peh, KK | 1 |
| Sandramouli, S | 1 |
| Williams, GP | 1 |
| Tsaloumas, MD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases With Benign Prostatic Hyperplasia[NCT03144596] | Phase 4 | 63 participants (Actual) | Interventional | 2015-10-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for doxazosin and Iris Diseases
| Article | Year |
|---|---|
Risk factors for intraoperative floppy iris syndrome: a meta-analysis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Diabetes Complications; Doxazosin; Humans; Hypertension; In | 2011 |
13 other studies available for doxazosin and Iris Diseases
| Article | Year |
|---|---|
Intraoperative floppy iris syndrome (IFIS) in patients receiving tamsulosin or doxazosin-a UK-based comparison of incidence and complication rates.
Topics: Adrenergic alpha-1 Receptor Antagonists; Atropine; Doxazosin; Drug Therapy, Combination; Female; Hum | 2013 |
Intraoperative floppy iris syndrome (IFIS): what complication rates can we expect?
Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Female; Humans; Intraoperative Complications; Ir | 2014 |
The effect of various alpha1-adrenergic receptor antagonists on pupillary dilation.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Iris Disea | 2008 |
Intraoperative floppy-iris syndrome associated with systemic alpha blockers.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosi | 2008 |
Pharmacologic pupil dilation as a predictive test for the risk for intraoperative floppy-iris syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cohort Studies; Doxazosin; Drug Combinations; Humans; | 2011 |
Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg?
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Do | 2005 |
Association of IFIS and vasodepressor medication.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Hypertensi | 2006 |
Intraoperative floppy iris syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Doxazosin; Humans; Hyal | 2006 |
Intraoperative floppy iris syndrome with doxazosin.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Doxazosin; Humans; Intraoperative Complicatio | 2007 |
Alpha antagonists and intraoperative floppy iris syndrome (IFIS) during trabeculectomy.
Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Doxazosin; Humans; Iris Diseases; Male; | 2007 |
Intraoperative floppy-iris syndrome with doxazosin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosi | 2007 |
Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha1-adrenoceptor antagonist.
Topics: Administration, Topical; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adul | 2007 |
The use of intracameral phenylephrine in the management of intraoperative floppy-iris syndrome with doxazosin.
Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Doxazosin; Humans; Intraoperative Compl | 2008 |